Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Hypoglycemia is described as blood sugar levels below 70 milligrams per deciliter. It's most commonly seen in people with diabetes, especially type 1 diabetes. Low glucose symptoms include ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the inci ...

Objective Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether ...

Drug-induced hypoglycemia describes when certain drugs may cause blood sugar levels to drop too low. It can occur with diabetes drugs, beta-blockers, alcohol, and certain pain relievers.

A Japanese study has found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics when their blood sugar levels drop, can potentially make diabetic ...

“Continuous glucose monitors with low-glucose alerts can potentially reduce the risk of hypoglycemia for insulin-treated ...

A thorough review of 21 cases involving acutely ill children associated with these products raises concerns. Researchers ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The following is a summary of “Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.